Quick Takeaways
- Alta Partners LLC filed SCHEDULE 13G for AEON Biopharma, Inc. Common Stock (AEON).
- Disclosed ownership: 6.2%.
- Date of event: 28 Feb 2025.
Alta Partners LLC - 28 Feb 2025 SCHEDULE 13G Report for AEON Biopharma, Inc. Common Stock (AEON)
- Filing Manager
- Alta Partners LLC
- Reporting Manager
- Alta Partners LLC
- Security
- AEON Biopharma, Inc. Common Stock
- Symbol
- AEON
- Shares outstanding
- 10,106,164 shares
- Disclosed Ownership
- 629,614 shares
- Ownership
- 6.2%
- Form type
- SCHEDULE 13G
- Filing time
- 10 Mar 2025, 08:45:25 UTC
- Date of event
- 28 Feb 2025
- Next filing
- 09 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Alta Partners LLC disclosed 6.2% ownership in AEON Biopharma, Inc. Common Stock (AEON) on 28 Feb 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Mar 2025, 08:45.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Alta Partners LLC | 6.2% | 629,614 | 629,614 | 0 | /s/ Steven Cohen | Steven Cohen, Managing Member |